Completed NA INTERVENTIONAL 2-arm NCT02843529

Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) (AltoidaML)

Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) as a Pre-Clinical or Pro-Dromal Alzheimers Diagnosis (Prognosis) for Optimum Outcomes

Sponsor: Altoida

Conditions Alzheimer Disease Cognitive Impairment Dementia Memory Disorders Mild Cognitive Impairment Presymptomatic Disease

Interventions Altoida: neuropsychological, MRI, EEG and CSF biomarkers

Updated 25 times since 2017 Last updated: Jul 30, 2024 Started: Oct 17, 2016 Primary completion: Feb 18, 2020 Completion: Feb 21, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Alzheimer Disease and Cognitive Impairment and is currently completed. Altoida leads this study, which shows 25 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

25 versions recorded

Mar 2025 — Present [monthly]

Completed NA
Feb 2025 — Mar 2025 [monthly]

Completed NA
Sep 2024 — Feb 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2024 — Jul 2024 [monthly]

Completed NA

▶ Show 20 earlier versions

Feb 2023 — Apr 2024 [monthly]

Completed NA
Jan 2023 — Feb 2023 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Feb 2021 — Dec 2022 [monthly]

Completed NA
Jan 2021 — Feb 2021 [monthly]

Completed NA
Jun 2020 — Jan 2021 [monthly]

Completed NA
Mar 2020 — Jun 2020 [monthly]

Completed NA
Feb 2020 — Mar 2020 [monthly]

Completed NA
Jan 2020 — Feb 2020 [monthly]

Completed NA
Dec 2019 — Jan 2020 [monthly]

Completed NA

Status: Enrolling By Invitation → Completed
Nov 2019 — Dec 2019 [monthly]

Enrolling By Invitation NA
Jul 2019 — Nov 2019 [monthly]

Enrolling By Invitation NA
Jun 2019 — Jul 2019 [monthly]

Enrolling By Invitation NA
Jun 2018 — Jun 2019 [monthly]

Enrolling By Invitation NA
Apr 2018 — Jun 2018 [monthly]

Enrolling By Invitation NA
Jan 2018 — Apr 2018 [monthly]

Enrolling By Invitation NA
Dec 2017 — Jan 2018 [monthly]

Enrolling By Invitation NA
Jun 2017 — Dec 2017 [monthly]

Enrolling By Invitation NA
Feb 2017 — Jun 2017 [monthly]

Enrolling By Invitation NA
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Altoida
Bioinformatics and Human Electrophysiology Laboratory
EIT Health
Fundacion Clinic per a la Recerca Biomédica
Global Brain Health Institute (GBHI)
Greek Alzheimer's Association and Related Disorders
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Klinik Hirslanden, Zurich
Neuromed IRCCS
Research Center on Computational BioMarkers
Scripps Health
Takeda Pharmaceuticals International, Inc.
The University of Texas at Dallas
University of Barcelona
University of Dublin, Trinity College
University of Roma La Sapienza

Data source: Altoida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.